Navigation Links
Anesthesia Drugs Market to Grow to $4.3 Billion by 2011 as Populations and Uses for Anesthesia Increase
Date:10/12/2007

NEW YORK, Oct. 12 /PRNewswire/ -- New products, a growing world population expected to reach 6.8 billion in three years, as well as the aging of that population, will push anesthesia drug sales 1.9% to nearly $4.3 billion by 2011, according to Anesthesia Drugs: Worldwide Markets, a new report by Kalorama Information.

More than 300 million surgical procedures required anesthetic administration worldwide in 2006, and Kalorama Information expects that number will rise accordingly as the incidence and prevalence of disease grows with the world population.

Adjunctive therapies, drugs given in the perioperative period to facilitate and/or augment the anesthetic process, will likely represent the largest percentage of growth during the forecast period primarily due to new developments in the anesthesia reversal market. The adjunctive therapies market grew from $793.3 million in 2004 to $825.5 million in 2006 and is expected to reach $1.2 billion by 2011, an increase of 8.2%.

Trends affecting future growth of anesthesia drugs include research and development in several promising areas, including the treatment of depression and sleep disorders and the growing use of conscious sedation, a procedure that involves sedative drugs that lower the level of consciousness but doesn't put a patient completely under.

"The availability of sedating drugs, such as fentanyl and Versed, has been a real boon to the industry," said Melissa Elder, author of Anesthesia Drugs. "Advancements in the area of conscious sedation have resulted in nearly 70% of surgical procedures being performed in hospital outpatient departments, surgical centers, and doctor's offices, which allow doctors to perform operations ranging from tummy tucks to cardiac catheterizations without the need for general anesthesia or an overnight hospital stay."

Anesthesia Drugs covers both currently marketed and late stage development anesthesia drugs worldwide with special emphasis on general, local, and adjunctive therapies in anesthesia in the U.S. The report analyzes products in development and on the market, leading competitors, and current issues and trends affecting the industry. This report can be purchased directly from Kalorama Information by visiting https://www.kaloramainformation.com/Anesthesia-Drugs-Worldwide-1399472/. It is also available at MarketResearch.com.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research on medical markets. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.KaloramaInformation.com.


'/>"/>
SOURCE Kalorama Information
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. General Anesthesia For Heroin Detoxification Is No Good
4. Anesthesia Drug To Bring Solace To The Depressed
5. Choice of Anesthesia in C-section
6. Dental Researchers Test No-Needle Anesthesia, No-Drilling Cavity Care
7. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
8. Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists
9. Two New Anesthesia Positions Promise to Ease Surgery Queue
10. Lean Protein Could Be Key to Obesity Drugs
11. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit ... at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical ... to donate. , “Women’s Hospital at Renaissance has been a collection partner for ...
(Date:4/28/2017)... Boston, MA (PRWEB) , ... April 28, 2017 , ... ... just for older people. “Wearing a hearing aid doesn’t have the stigma it had ... Speech-Language & Hearing Associates of Greater Boston, in a NALA North American Speaker ...
(Date:4/28/2017)... Pensacola, FL (PRWEB) , ... April 28, 2017 ... ... Tampa, Florida are conducting a pilot study of ActiGraph’s CentrePoint Data ... ActiGraph is a leading provider of clinical-grade wearable activity and sleep monitoring solutions ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... celebrating its 5th anniversary. SearchLight is the premier online modeling resource for fluorescence ... more than 30,000 active users during last 5 years spanning the globe, SearchLight ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... , April 19, 2017 Global Surgical Drainage ... are tubes used to remove excess liquid and air. ... pus, urine, bile or lymph. Surgical drains are used ... such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery ... post-surgery to prevent accumulation of fluid e.g. blood or ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: